MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 983-991

  Yang, Muhua ^a   Yao, Yuan ^a   Eades, Gabriel ^a   Zhang, Yongshu ^a   Zhou, Qun ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chemoprevention; Mammary epithelial cells; miR 28; Nrf2

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA; MICRORNA 28; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA DEGRADATION;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUCIFERASES; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTATION; NF-E2-RELATED FACTOR 2; PROTEIN STABILITY; RNA, MESSENGER;

EID: 80052570740     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1604-1     Document Type: Article

References (46)

1. S Yu A Kong 2007 Targeting carcinogen metabolism by dietary cancer preventive compounds Curr Cancer Drug Targets 7 416 424 17691900 10.2174/156800907780058817 1:CAS:528:DC%2BD2sXhtVKqsLjM (Pubitemid 46348628)
2. WR Fields CS Morrow J Doehmer, et al. 1999 Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1 Carcinogenesis 20 1121 1125 10357798 10.1093/carcin/20.6. 1121 1:CAS:528:DyaK1MXjvVKjtL8%3D (Pubitemid 29263761)
3. CJ Henderson AG Smith J Ure, et al. 1998 Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases Proc Natl Acad Sci USA 95 5275 5280 9560266 10.1073/pnas.95.9.5275 1:CAS:528:DyaK1cXivV2jt7Y%3D (Pubitemid 28208588)
4. M Ramos-Gomez MK Kwak PM Dolan, et al. 2001 Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice Proc Natl Acad Sci USA 98 3410 3415 11248092 10.1073/pnas.051618798 1:CAS:528:DC%2BD3MXit1altb8%3D (Pubitemid 32220859)
5. M Ramos-Gomez P Dolan K Itoh, et al. 2003 Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice Carcinogenesis 24 461 467 12663505 10.1093/carcin/24.3.461 1:CAS:528: DC%2BD3sXjslagsb8%3D (Pubitemid 36432641)
6. M McMahon K Itoh M Yamamoto, et al. 2001 The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes Cancer Res 61 3299 3307 11309284 1:CAS:528:DC%2BD3MXjtFSjtb4%3D (Pubitemid 32695017)
7. CJ Harvey RK Thimmulappa A Singh, et al. 2009 Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress Free Radic Biol Med 46 443 453 19028565 10.1016/j. freeradbiomed.2008.10.040 1:CAS:528:DC%2BD1MXhtlCktbc%3D
8. A Barve T Khor S Nair, et al. 2009 Gamma-tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice Int J Cancer 124 1693 1699 19115203 10.1002/ijc.24106 1:CAS:528:DC%2BD1MXivVars7c%3D
9. A Acharya I Das D Chandhok, et al. 2010 Redox regulation in cancer: a double-edged sword with therapeutic potential Oxid Med Cell Longev 3 1 23 34 20716925 10.4161/oxim.3.1.10095
10. T Hsieh S Elangovan J Wu 2010 Differential suppression of proliferation in MCF-7 and MDA-MB-231 breast cancer cells exposed to alpha-, gamma- and delta-tocotrienols is accompanied by altered expression of oxidative stress modulatory enzymes Anticancer Res 30 4169 4176 21036737 1:CAS:528:DC%2BC3MXktFyh
11. Y Yao AMH Brodie N Davidson, et al. 2010 Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer Breast Cancer Res Treat 124 585 591 20623181 10.1007/s10549-010-1023-8 1:CAS:528:DC%2BC3cXht12qur%2FN
12. A Singh V Misra R Thimmulappa, et al. 2006 Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer PLoS Medicine 3 e420 17020408 10.1371/journal.pmed.0030420 (Pubitemid 44721825)
13. T Ohta K Iijima M Miyamoto, et al. 2008 Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth Cancer Res 68 1303 1309 18316592 10.1158/0008-5472.CAN-07-5003 1:CAS:528:DC%2BD1cXislagtbo%3D (Pubitemid 351346836)
14. A Dinkova-Kostova WD Holtzclaw R Cole, et al. 2002 Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants Proc Natl Acad Sci USA 99 11908 11913 12193649 10.1073/pnas.172398899 1:CAS:528:DC%2BD38XntFWqtb0%3D (Pubitemid 34994497)
15. N Wakabayashi A Dinkova-Kostova WD Holtzclaw, et al. 2004 Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers Proc Natl Acad Sci USA 101 2040 2045 14764894 10.1073/pnas.0307301101 1:CAS:528: DC%2BD2cXhs1Sku7k%3D (Pubitemid 38229011)
16. M Kobayashi M Yamamoto 2006 Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species Adv Enzyme Regul 46 113 140 16887173 10.1016/j.advenzreg.2006.01.007 1:CAS:528:DC%2BD1cXhs12ltLc%3D (Pubitemid 44301353)
17. SK Niture JW Kaspar J Shen AK Jaiswal 2010 Nrf2 signaling and cell survival Toxicol Appl Pharmacol 244 1 37 42 19538984 10.1016/j.taap.2009.06.009 1:CAS:528:DC%2BC3cXjt1Gkt7Y%3D
18. J Kaspar S Niture A Jaiswal 2009 Nrf2:INrf2 (Keap1) signaling in oxidative stress Free Radic Biol Med 47 1304 1309 19666107 10.1016/j. freeradbiomed.2009.07.035 1:CAS:528:DC%2BD1MXht1yjtbnM
19. W Miao L Hu PJ Scrivens, et al. 2005 Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signaling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes J Biol Chem 280 20340 20348 15790560 10.1074/jbc.M412081200 1:CAS:528:DC%2BD2MXktlCmurg%3D (Pubitemid 40776732)
20. M Kwak K Itoh M Yamamoto T Kensler 2002 Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element-like sequences in the nrf2 promoter Mol Cell Biol 22 2883 2892 11940647 10.1128/MCB.22.9.2883-2892.2002 1:CAS:528:DC%2BD38XivFylsL0%3D (Pubitemid 34437448)
21. X Wang D Zhang 2009 Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level PLoS ONE 4 e5492 19424503 10.1371/journal.pone.0005492
22. S Yu T Khor K Cheung, et al. 2010 Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice PLoS ONE 5 e8579 20062804 10.1371/journal.pone.0008579
23. W Filipowicz S Bhattacharyya N Sonenberg 2008 Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9 102 114 18197166 10.1038/nrg2290 1:CAS:528:DC%2BD1cXnt1ensA%3D%3D
24. J Winter S Jung S Keller, et al. 2009 Many roads to maturity: microRNA biogenesis pathways and their regulation Nat Cell Biol 11 228 234 19255566 10.1038/ncb0309-228 1:CAS:528:DC%2BD1MXisVOltrg%3D
25. A Zimmerman S Wu 2011 MicroRNAs, cancer and cancer stem cells Cancer Lett 300 10 19 20965651 10.1016/j.canlet.2010.09.019 1:CAS:528:DC%2BC3cXhsVGns7%2FI
26. PM Voorhoeve R Agami 2007 Classifying microRNAs in cancer: the good, the bad and the ugly Biochim Biophys Acta 1775 274 282 17189674 1:CAS:528: DC%2BD2sXmsFKmtb4%3D (Pubitemid 46899338)
27. C Sangokoya M Telen J Chi 2010 microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease Blood 116 4338 4348 20709907 10.1182/blood-2009-04-214817 1:CAS:528: DC%2BC3cXhsFChsrzO
28. N Rosenfeld R Aharonov E Meiri, et al. 2008 MicroRNAs accurately identify cancer tissue origin Nat Biotechnol 26 462 469 18362881 10.1038/nbt1392 1:CAS:528:DC%2BD1cXktlymtbw%3D (Pubitemid 351501813)
29. C Corcoran A Friel M Duffy, et al. 2011 Intracellular and extracellular microRNAs in breast cancer Clin Chem 57 18 32 21059829 10.1373/clinchem.2010. 150730 1:CAS:528:DC%2BC3MXitFSlu7w%3D
30. T Farazi J Spitzer P Morozov, et al. 2011 miRNAs in human cancer J Pathol 223 102 115 21125669 10.1002/path.2806 1:CAS:528:DC%2BC3MXltleiug%3D%3D
31. F Gottardo C Liu M Ferracin, et al. 2007 Micro-RNA profiling in kidney and bladder cancers Urol Oncol 25 387 392 17826655 10.1016/j.urolonc.2007.01.019 1:CAS:528:DC%2BD2sXhtVWhtrzL (Pubitemid 47362758)
32. B Malzkorn M Wolter F Liesenberg, et al. 2010 Identification and functional characterization of microRNAs involved in the malignant progression of gliomas Brain Pathol 20 539 550 19775293 10.1111/j.1750-3639.2009.00328.x 1:CAS:528:DC%2BC3cXmt1aksLY%3D
33. M Girardot C Pecquet S Boukour, et al. 2010 miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets Blood 116 437 445 20445018 10.1182/blood-2008-06- 165985 1:CAS:528:DC%2BC3cXhtVejt7jM
34. W Fan Z Tang D Chen, et al. 2010 Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy Autophagy 6 614 621 10.4161/auto.6.5.12189 1:CAS:528:DC%2BC3cXhtVGlsL7E
35. M Furukawa Y Xiong 2005 BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase Mol Cell Biol 25 162 171 15601839 10.1128/MCB.25.1.162-171.2005 1:CAS:528: DC%2BD2MXis1Gisg%3D%3D (Pubitemid 40039808)
36. H Zhou K Mazan-Mamczarz J Martindale, et al. 2010 Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer Nucleic Acids Res 38 3619 3631 20159994 10.1093/nar/gkq084 1:CAS:528:DC%2BC3cXnvVOit7s%3D
37. A Agoston P Argani S Yegnasubramanian, et al. 2005 Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer J Biol Chem 280 18302 18310 15755728 10.1074/jbc.M501675200 1:CAS:528: DC%2BD2MXjsl2ht78%3D (Pubitemid 41389076)
38. T Kensler N Wakabayashi 2010 Nrf2: friend or foe for chemoprevention? Carcinogenesis 31 90 99 19793802 10.1093/carcin/bgp231 1:CAS:528: DC%2BC3cXktlCgsQ%3D%3D
39. W Xu J Li L Fan, et al. 2009 Expressions of bcl-6, lpp and miR-28 genes in diffuse large B cell lymphoma cell lines Zhong Guo Shi Yan Xue Ye Xue Za Zhi 17 83 87 1:CAS:528:DC%2BD1MXhtlSmtrnK
40. L Li Z Zhang Y Liu, et al. 2010 DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx Zhong Hua Bing Li Xue Za Zhi 39 391 395
41. A Eulalio E Huntzinger E Izaurralde 2008 Getting to the root of miRNA-mediated gene silencing Cell 132 9 14 18191211 10.1016/j.cell.2007.12.024 1:CAS:528:DC%2BD1cXhtFehtLo%3D
42. S Nottrott M Simard J Richter 2006 Human let-7a miRNA blocks protein production on actively translating polyribosomes Nat Struct Mol Biol 13 1108 1114 17128272 10.1038/nsmb1173 1:CAS:528:DC%2BD28Xht1KrurnE (Pubitemid 44885922)
43. J Klaunig L Kamendulis B Hocevar 2010 Oxidative stress and oxidative damage in carcinogenesis Toxicol Pathol 38 96 109 20019356 10.1177/ 0192623309356453 1:CAS:528:DC%2BC3cXjt1ajtb4%3D
44. M Kwak T Kensler 2010 Targeting NRF2 signaling for cancer chemoprevention Toxicol Appl Pharmacol 244 66 76 19732782 10.1016/j.taap.2009.08.028 1:CAS:528:DC%2BC3cXjt1GktLs%3D
45. G Rachakonda KR Sekhar D Jowhar, et al. 2010 Increased cell migration and plasticity in Nrf2-deficient cancer cell lines Oncogene 29 3703 3714 20440267 10.1038/onc.2010.118 1:CAS:528:DC%2BC3cXlsVyitbY%3D
46. C Havens A Ho N Yoshioka, et al. 2006 Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species Mol Cell Biol 26 4701 4711 16738333 10.1128/MCB.00303-06 1:CAS:528:DC%2BD28XlvVequ7g%3D (Pubitemid 43877586)